Compounding Errors: Corrective Actions - PowerPoint PPT Presentation

1 / 59
About This Presentation
Title:

Compounding Errors: Corrective Actions

Description:

Compounding Errors: Corrective Actions – PowerPoint PPT presentation

Number of Views:219
Avg rating:3.0/5.0
Slides: 60
Provided by: gregfi2
Category:

less

Transcript and Presenter's Notes

Title: Compounding Errors: Corrective Actions


1
Compounding Errors Corrective Actions
Medical Seminar Presented By Malcolm H. Philips,
Jr. CEO, CDEX Inc.
2
Problem this Seminar Addresses
  • One is Correct, One Will Permanently Harm a
    Patient!
  • Can You Tell the Difference?

3
Seminar Purpose
  • Understand Impacts and underlying causes of
    critical compounding errors that most impact
    patients
  • Develop strategies for addressing these causes
  • Understanding how to implement and monitor
    strategies that may be most helpful

4
Seminar Approach
  • Examine Global Studies of Compounding Practices
  • Draw Conclusions on the Primary Problems that
    Cause the Greatest Harm to Patients
  • Discuss Strategies to Minimize Those Problems
  • Analyze How to Implement Those Strategies

5
What Do Studies Show? March 12, 2009 report
published in the BritishMedical Journal (BMJ
2009338b814)
  • Scope Errors in administering IV drugs to1300
    patients in 113 ICUs over a 24-hour period across
    27 countries errors are universal
  • 441 patients affected by medication errors (many
    with two errors), 12 permanently harmed, 5 deaths
  • While only 20 of the errors relate to wrong
    drug/dose, 50 of permanent harm and 60 of
    deaths related to wrong drug/dose
  • Self reporting bias errors underreported

6
What Do Studies Show? January 1, 2008 18 Month
Study for verification of High Risk IV
Medications (Am J Health-Syst Pharm--Vol 65, pp
49-54)
  • Study led by Dr. Jim Stevenson, Director of
    Pharmacy Services University of Michigan
    Hospitals and Health Centers and Professor and
    Associate Dean for Clinical Sciences University
    of Michigan College of Pharmacy
  • Pharmacist of the Year Michigan Society of
    Health-system Pharmacists and the Michigan
    Pharmacists Association
  • Board of Directors of the American Society of
    Health-system Pharmacists

7
What Do Studies Show? 1/1/08 18 Month Study
for verification of High Risk IV Medications (Am
J Health-Syst Pharm--Vol 65, pp 49-54). Recipient
of the ASHP 2009 Pharmacy Practice Research Award
  • Scope C.S. Mott Childrens Hospital (one of the
    best in the US), 18 months analysis of 7
    med/dose/diluent compounded combinations
  • All Meds tested by ValiMed after all final
    checks
  • Samples rejected by ValiMed sent out to labs for
    confirmation testing
  • Results 5 major medication errors were caught
    all were wrong drug or dose errors that would
    have substantially harmed patients

8
What Do Studies Show? Consistent Conclusions
  • Errors Reported Generally Underestimate Errors
    Made Self Reporting and Observation Bias
  • Wrong Drug/Dose Errors Cause Disproportionately
    Higher Permanent Injuries
  • Despite best efforts of good, well trained people
    major medication errors continue to be made
  • Average Pharmacy compounding 7 or more
    medications will likely make at least 5 major
    wrong drug or wrong dose medication errors over
    an 18 month period

9
Impacts of Major Medication Errors
  • Life Long Impact on Patient and Family
  • Life Long Emotional Impact on Pharm Tech who made
    the Compounding Mistake
  • Major Impact on the Medical Institution
  • Reputation
  • Financial
  • Major Impact on the Director of Pharmacy
  • Emotional, Career, Potential Penalties

10
What is the Culprit?
  • Studies Consistently Show that HUMAN ERROR is at
    the root of virtually all wrong drug/wrong dose
    compounding errors
  • Human error is a constant in virtually all
    industries
  • We must accept human error as inevitable and
    design around that fact.
  •  Donald Berwick, MD, MPP, President and CEO,
    Institute for Health Care Improvement
  •  

11
Human Errors -- How to Minimize them?
  •   Procedural Controls and Standardization
  • Standardize the way compounding is performed
  • Written Procedures
  • Staff Acceptance (Use Team Development)
  • Accepted Practice by All Major Industries
  • Problem How to Objectively Monitor Results
    How do you know that you are really improving the
    end performance?

12
Objective Data Supports Standardization ValiMed
Chart shows 2 techs in the same pharmacy
compounded 5 samples of Gentamycin 4mg/ml D5W.
Each was consistent for their 5 samples. One was
wrong! If you do not have standardization, this
is happening in your pharmacy today!
13
Human Errors -- How to Minimize them?
  •   Organizational Controls and Improvements
  • Physical Organizational Changes Simplify,
    Simplify, Simplify
  • Staff Organizational Changes The Right Org with
    the Right People in the Right Places!
  • Does Redundancy Help?
  • Somewhat, but redundancy and diversity minimize
    common mode failures!
  • Problem How to Objectively Monitor Results
    How do know that you are really improving the end
    performance?

14
After Changes, you should be able to Objectively
Observe greater compounding Accuracy!
How?ValiMed Report Showing compounding Accuracy
of every sample of any Med, Compounded by any or
All Pharm techs (or robotics) over time
  •  q

15
Human Errors -- How to Minimize them?
  •   Personnel Hiring and Review Practices
  • Assure New Hires have Compounding Aptitude
    (testing for precision, withstanding stress,
    etc)
  • Annual Reviews Check Compounding performance
    against set standards people focus on what the
    boss focuses on!
  • Problem How to Objectively Monitor Results
    How do you know that you are really improving the
    end performance?

16
During Personnel reviews, You should be able to
Discuss objectively the compounding accuracy of
any Member of youR staff! How?ValiMed Report of
compounding accuracy of each pharm tech over time
per Medication.
  •  

17
Human Errors -- How to Minimize them?
  •   New Employee and On the Job Training
  • New Employee Training is essential to set
    standards and teach the system used
  • Refresher training is essential to maintain
    standards set and constantly reinforce your
    personal expectations
  • Problem How to Objectively Monitor Results
    How do you know you are really improving the end
    performance?

18
ValiMed Provides real-time, OJT feedback of
compounding accuracy that improves compounding
performance people want to do a good job,
they simply need objective feedback to improve!
19
Human Errors -- How to Minimize them?
  •   Summary of Actions
  • Standardize Procedures Written and with Staff
    Buy In
  • Organizational Controls and Improvements
    Simplify and Provide both redundancy and
    diversity
  • Personnel Hiring and Review Practices Set Your
    Standards and Reinforce Them
  • New Employee and On the Job Training
  • CONTINUING PROBLEMS?

20
Human Errors -- How to Minimize them?
  •   Three Major Continuing Problems
  • Problem We must accept human error as
    inevitable and design around that fact. None
    of the Personnel Related Corrective Actions Will
    Eliminate Human Error
  • Problem How to Objectively Monitor Results So
    that you can know that you are really improving
    the end performance?
  • Problem How do you deal with harmful
    counterfeit medications?

21
Human Errors -- How to Stop them?
  •   Technological Safety Net (ValiMed) Between
    The Pharmacy and the Patient
  • Provides redundancy to and diversity from human
    checks of compounding accuracy
  • Provides objective monitoring of Compounding
    Practices individually and as a Group You can
    tell if your changes are really effective!
  • Provides instantaneous training feedback
  • Provides carryover improvement for all
    medications compounded
  • Rejects harmful counterfeit medications

22
ValiMed has the ability to take human error out
of the equation, save lives and give peace of
mind to everyone!
23
Break
  •  

24
  • Introducing ValiMed
  • Medication Validation System from CDEX, Inc
  • The Right Drug At The Right Dose

25
CDEX Inc Company Overview
26
Five potentially serious medication errors were
averted over an 18-month period in a test at C.S.
Mott Children's Hospital in the University of
Michigan Health System by using the ValiMed
technology.
"Errors in compounding these types of medications
are rare. However, when they occur they can have
a significant negative impact on patients and
staff "We know from having this technology in
place we've deterred five errors that might have
happened. I really believe having technology like
this needs to be the standard around the country
said Jim Stevenson, associate dean of Clinical
Sciences at the UM College of Pharmacy and
Director of Pharmacy Services at the U-M Health
System
27
Examples of Errors caught by ValiMed
  • Vancomycin 50 under dose in bulk compounding.
  • Morphine 300 overdose
  • Lorazepam 2000 overdose
  • Dopamine and Dobutamine Interchanging
  • Lorazepam Not dispersing high viscosity
    lorazepam in the total mixture. risk of hot zones
  • Dopamine Mistaken use of naloxone instead of
    dopamine in the compounded solution
  • Significant dilution of return Fentanyl
    potential diversion

28
The Technology How it Works Complex
Technology Made Deceptively Simple
ValiMed uses a technology referred to as Enhanced
Photoemission Spectroscopy to validate
medications. ValiMed generates high energy UV
light energy which excites the medication sample.
As a result, the sample produces a unique UV
response that ValiMed compares to a reference
signature stored in an internal database.
29
The Technology How it Works Complex
Technology Made Deceptively Simple
Each medication reveals its own distinct and
easily readable signature. By comparing the
fingerprints of a tested medication against the
signature for that medication in our data
library, the ValiMed technology indicates
virtually in real time a match, presuming there
is one.
This Chart shows ValiMeds ability to indicate
the concentration of a given medication. The
tested concentration also can be validated by
comparing it to the standard concentration on
file in the data library.
30
ValiMed Solutions Applications
31
Patient Safety Solution
  • Medication errors are among the most common
    medical errors, harming at least 1.5 million
    people every year in the United States, costing
    the nation at least 3.5 billion.
  • On average, there is at least one medication
    error per hospital patient per day and studies
    indicate that 400,000 preventable drug-related
    injuries occur each year in US hospitals.
  • Bar coding and double checks can help catch
    errors but, until now, there has been no cost
    effective, time-sensitive means to objectively
    check liquid medication prior to them leaving the
    pharmacy or being administered to the patient.
  • The ValiMed Patient Safety Solution provides
    validation of IV admixtures (including high alert
    medications) at the time of compounding. ValiMed
    provides the assurance that medications have been
    prepared accurately. This reduces undetected
    errors in medication selection, the manufacturing
    of admixtures, inadvertent substitution,
    purposeful counterfeiting or the mislabeling of
    the medication, container or package.

32
Narcotics Return Solution
  • Clinicians shoulder a burden most of their fellow
    citizens do not easy access to controlled
    substances. As many as 9 of clinicians with
    access to controlled substances are, in the
    discreet language of the professional,
    impaired.
  • ASHPs Guidelines on Surgery and Anesthesiology
    Pharmaceutical Services, recommends Qualitative
    testing of returned controlled substances.
  • The ValiMed Narcotics Return Solution provides
    fast, easy, accurate and OBJECTIVE analysis of
    returned narcotics (including Fentanyl) prior to
    disposal and use.
  • ValiMed can help identify problem areas before
    they become crises while meeting regulatory
    guidelines for the accounting of controlled
    substances.

33
Counterfeit Medication Solution
  • According to the OECD, up to 15 of all drugs
    around the world are counterfeit (Up to 60 of
    drugs in developing countries).
  • Counterfeit drugs account for 32 billion
    annually and could potentially grow to 75/
    billion annually in 5 years.
  • Counterfeit Drugs from originally lifestyle drugs
    (Viagra, Oxycontin) to lifesaving drugs
    (AIDS/HIV therapy, over-the-counter pain
    medications, antibiotics, insulin, cholesterol
    drugs, medications, cancer drugs, antiarthritis
    drugs, cardiac drugs, anti-parasitic drugs,
    antihistamines ... and more that are
    undiscovered).
  • The ValiMed Counterfeit Medication Solution
    diminishes the risk of counterfeiting at any
    point in the supply chain from the manufacturer
    to the wholesaler to the distributor to the
    hospital to the retailer.
  • ValiMed provides assurance that the medication is
    indeed an authentic product from the
    manufacturing facility. Real time medication
    validation provides the ability to spot
    counterfeits and easily generate reports for
    quality assurance documentation.

34
Compliance Training Solution
  • Pharmacies are required to comply with guidelines
    almost as strict as those required of
    pharmaceutical manufacturers. This includes
    standards in technique, training, and
    environmental concerns. The USP, ASHP, JCAHO, and
    the State Boards of Pharmacy are working to
    update the standards that regulate how pharmacies
    compound sterile preparations.
  • USP lt797gt states that a provider of Compounded
    Sterile Products (CSPs) must have in place a QA
    Program intended to provide a mechanism for
    monitoringactivities and processes and must
    demonstrate effectiveness of all procedures
    critical to the accuracy and purity of finished
    CSPs Such testing can be very costly and time
    consuming.
  • The ValiMed Regulatory Compliance Solution
    provides validation of your sterile preparations
    and documentation of your quality process to meet
    the USP lt797gt recommendations and other
    regulatory guidelines.

35
Compliance Training Solution
  • ValiMed provides the assurance that sterile
    admixtures have been compounded accurately.
  • Daily activity reports can be easily generated to
    comply with regulations / guidelines and to
    facilitate JCAHO or other quality assurance
    surveys.
  • ValiMed plays an important role in the training
    and continued education of pharmacy staff and
    care givers involved in the compounding and
    administration of high-risk IV admixtures.

36
ValiMed sets New Safety Standards
  • The ValiMed Medication and Narcotic Validation
    System brings unique value to hospital medication
    safety programs and quality control processes by
  • Providing immediate, real-time validation of the
    substance itself
  • Providing an opportunity to standardize and
    optimize internal medication safety processes
    including Training, Auditing QA and Regulatory
    Compliance.
  • Providing a real-time means of validating
    narcotic returns and mitigating narcotic
    diversion
  • Providing pharmacy staff and clinicians with a
    simple, fast, straightforward and cost-effective
    way to ensure that the RIGHT drug in the RIGHT
    dose is administered to the patient.

37
ValiMed Key Features
  • Touch screen menu
  • Only 0.15 ml sample required
  • Average Test less than 30 seconds
  • Ability to print and export reports
  • Right Medication
  • Right Concentration
  • No Interpretation of Results means Protection
    for users

38
ValiMed Touch Screen
39
Test result window flashes green for successful
test, red for failure. Also produces audible
result validated/not validated and gives
immediate feedback on compounding accuracy
40
ValiMed Provides real-time and objective
feedback of compounding accuracy that improves
compounding performance people want to do a
good job, they simply need objective feedback to
improve!
41
ValiMed Drug Validation Report- A Record of
Acceptance that gives Peace of Mind!
42
After Changes, you should be able to Objectively
Observe greater compounding Accuracy!
How?ValiMed Report Showing compounding Accuracy
of every sample of any Med Tested over time
  •  q

43
During Personnel reviews, You should be able to
Discuss objectively the compounding accuracy of
any Member of youR staff! How?ValiMed Report of
compounding accuracy of each person over time per
Medication.
  •  

44
Pharm Tech Compounding Variations of Cefuroxime
25mg/ml D5W (Data from ValiMed)
45
Deter Narcotic Diversion with ValiMed EPSIs
this happening in your pharmacy? (red 50
fentanyl vs. blue 100 fentanyl)
46
ValiMed Main Benefits
47
ValiMed Medication Signatures
  • Robust medication signatures have been developed
    from nearly 400 individual medication sample
    scans ensuring accurate readings every time.
  • Development of new medication signatures based on
    client needs is a CDEX priority. We currently
    have 200 signatures in our library as of Oct 1st
    and continue expanding it driven now by customer
    request.
  • We want to know what your signature needs are and
    we will work with you to develop new signatures
    to meet those needs.
  • The following list shows and example of
    signatures that are currently available to our
    clients.

48
ValiMed Medication Signature Library, (example)
  • Acyclovir 5 mg-ml NS EPT
  • Acyclovir 10 mg-ml SW EPT
  • Acyclovir 5 mg-ml SW EPT
  • Acyclovir 10 mg-ml NS EPT
  • Acyclovir 7 mg-ml SW EPT
  • Amikacin 10 mg-ml NS EPT
  • Amikacin 5 mg-ml NS EPT
  • Amikacin 10 mg-ml D5W EPT
  • Amikacin 5 mg-ml D5W EPT
  • Amiodarone 1.8 mg-ml D5W EPT
  • Ampicillin 20 mg-ml NS EPT
  • Ampicillin 100 mg-ml SW EPT
  • Ampicillin-Sulbactam 20 mg-ml NS EPT
  • Ampicillin-Sulbactam 45 mg-ml NS EPT
  • Ampicillin-Sulbactam 30 mg-ml NS EPT
  • Cefazolin 125 mg-ml D5W EPT
  • Cefazolin 20 mg-ml D5W EPT
  • Cefazolin 50 mg-ml D5W EPT
  • Cefazolin 100 mg-ml SW EPT
  • Epinephrine 0.05 mg-ml NS EPT
  • Epinephrine 0.008 mg-ml
    NS EPT
  • Epinephrine 0.05 mg-ml D10W EPT
  • Epinephrine 0.02 mg-ml D5W EPT
  • Fentanyl 10 mcg-ml D5W EPT
  • Fentanyl 50 mcg-ml NR
  • Gentamicin 10 mg-ml D5W EPT
  • Gentamicin 10 mg-ml NS EPT
  • Gentamicin 4 mg-ml D5W EPT
  • Dobutamine 0.5 mg-ml D5W EPT
  • Dobutamine 1 mg-ml D5W EPT
  • Dobutamine 1 mg-ml D10W EPT
  • Dobutamine 0.5 mg-ml NS EPT
  • Dobutamine 2 mg-ml D10W EPT
  • Dobutamine 2 mg-ml D5W EPT
  • Dobutamine 4 mg-ml D5W EPT
  • Dopamine 1 mg-ml D5W EPT
  • Dopamine 0.5 mg-ml NS EPT
  • Dopamine 1 mg-ml D10W EPT

49
ValiMed Medication Signature Library, page 2
(example)
  • Gentamicin 5 mg-ml D5W EPT
  • Heparin 5 units-ml NS EPT
  • Heparin 7 units-ml 1/2 NS EPT
  • Heparin 1 units-ml NS EPT
  • Heparin 3 units-ml NS EPT
  • Heparin 7 units-ml NS EPT
  • Heparin 10 units-ml 1/2 NS EPT
  • Heparin 3 units-ml 1/2 NS EPT
  • Hydrocortisone 5 mg-ml D5W EPT
  • Hydromorphone 0.4 mg-ml NS EPT
  • Hydromorphone 0.5 mg-ml NS EPT
  • Hydromorphone 0.2 mg-ml BNS EPT
  • Hydromorphone 0.5 mg-ml BNS EPT
  • Hydromorphone 2 mg-ml NR
  • Hydromorphone 2 mg-ml BNS EPT
  • Hydromorphone 0.2 mg-ml NS EPT
  • Hydromorphone 0.1 mg-ml NS EPT
  • Insulin 0.1 units-ml NS EPT
  • Insulin 0.1 units-ml D10W EPT
  • Methadone 1 mg-ml NS EPT
  • Metoclopramide 0.5 mg-ml
    NS EPT
  • Metoclopramide 0.5 mg-ml D5W EPT
  • Midazolam 5 mg-ml NR
  • Midazolam 1 mg-ml D5W EPT
  • Morphine 1 mg-ml NS NR
  • Morphine 1 mg-ml D5W EPT
  • Morphine 1 mg-ml BSW EPT Morphine 1 mg-ml NS EPT
  • Morphine 15 mg-ml D5W EPT
  • Morphine 2 mg-ml NS EPT
  • Morphine 1.5 mg-ml NS EPT
  • Morphine 3 mg-ml NS EPT
  • Morphine 10 mg-ml NR
  • Morphine 4 mg-ml NR
  • Morphine OC 20 mg-ml NR
  • Morphine PF 0.5 mg-ml NR
  • Norepinephrine 50 mcg-ml D5W EPT
  • Norepinephrine 200 mcg-ml D5W EPT
  • Norepinephrine 4 mcg-ml D5W EPT

50
Some of the finest US Hospitals already use the
CDEX ValiMed Medication Validation Systems
  • All Childrens Hospital, Inc. (St. Petersburg,
    Florida)
  • Brigham and Womens Hospital (Boston, MA)
  • Cedars-Sinai Medical Center (Los Angeles, CA)
  • Childrens Medical  Center of Dallas (Dallas
    Texas)
  • Cleveland Clinic Foundation (Cleveland, Ohio)
  • Geisinger Medical Center (Danville, PA)
  • Henry Ford Health System (Detroit, Michigan)
  • Loyola University Medical Center (Maywood,
    Illinois)
  • Mission Hospitals (Ashville, NC)
  • Primary Childrens Medical Center (Salt Lake
    City, Utah)
  • Stanford Hospitals and Clinics (Stanford,
    California)
  • U.C. Davis Health System (Sacramento, California)
  • University of Maryland Medical Center (Baltimore,
    Maryland)
  • University of Michigan Health System (Ann Harbor,
    Michigan)

51
Questions and Answers?
52
Questions?
  • www.ValiMed.com
  • www.CDEXINC.com
  • Gregory A Firmbach
  • 412-563-3355 (Eastern US offices)
  • or
  • 520-745-5172 (Corporate offices)
  • Email Greg.Firmbach_at_cdex-inc.com

53
EXTRA SLIDES FOR QUESTIONS AND ANSWERS
  • VALIMED

54
ValiMed Technical Specification
  • Amikacin 5 mg-ml D5W

55
ValiMed Technical Specification
56
ValiMed Technical Specification
57
ValiMed Model CCT SensitivityCCT MODEL vs VM
MODEL
58
INITIAL VALIMED SETUP (SAMPLES 1-10)(COMPOUNDED
BY MANY PTs TO SET THE INITIAL PARAMETERS)
59
INITIAL VALIMED SETUP FOR SAMPLES 11-67
SAMPLES WITH 0-3 SDs
SAMPLES WITH gt 7 SDs
SAMPLES WITH 3-7 SDs
SAMPLES THAT FAILED SIG
Write a Comment
User Comments (0)
About PowerShow.com